Back to search
5-methoxy-dimethyltryptamine (5-MeO-DMT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which 5-methoxy-dimethyltryptamine (5-MeO-DMT) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which 5-methoxy-dimethyltryptamine (5-MeO-DMT) trials you may qualify forThis is an observational study which does NOT directly administer a psychedelic substance but rather recruits participants who are already participating in anot…
Participation in this study lasts approximately two weeks and includes three on-site study visits: a screening visit (approximately 2 hours), a study drug admin…
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aero…
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aero…
The aim of this randomized, double-blind, placebo-controlled, phase 2b clinical trial is to investigate the safety and efficacy of GH001 (containing mebufotenin…
This study is a multicenter, open-label, single-arm Phase 2 clinical trial. Approximately 15 participants with clinically diagnosed bipolar disorder (BD) type I…